[go: up one dir, main page]

DE60324196D1 - Narcistatin-prodrugs - Google Patents

Narcistatin-prodrugs

Info

Publication number
DE60324196D1
DE60324196D1 DE60324196T DE60324196T DE60324196D1 DE 60324196 D1 DE60324196 D1 DE 60324196D1 DE 60324196 T DE60324196 T DE 60324196T DE 60324196 T DE60324196 T DE 60324196T DE 60324196 D1 DE60324196 D1 DE 60324196D1
Authority
DE
Germany
Prior art keywords
narcistatin
prodrugs
narcistatin prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324196T
Other languages
English (en)
Inventor
George R Pettit
Noeleen Melody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arizona
Arizona's Public Universities
Original Assignee
University of Arizona
Arizona's Public Universities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arizona, Arizona's Public Universities filed Critical University of Arizona
Application granted granted Critical
Publication of DE60324196D1 publication Critical patent/DE60324196D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60324196T 2002-12-09 2003-12-09 Narcistatin-prodrugs Expired - Lifetime DE60324196D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43221902P 2002-12-09 2002-12-09
PCT/US2003/039067 WO2004052298A2 (en) 2002-12-09 2003-12-09 Narcistatin prodrugs

Publications (1)

Publication Number Publication Date
DE60324196D1 true DE60324196D1 (de) 2008-11-27

Family

ID=32507871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324196T Expired - Lifetime DE60324196D1 (de) 2002-12-09 2003-12-09 Narcistatin-prodrugs

Country Status (4)

Country Link
US (2) US7462609B2 (de)
EP (2) EP1990346A3 (de)
DE (1) DE60324196D1 (de)
WO (1) WO2004052298A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462609B2 (en) * 2002-12-09 2008-12-09 Arizona Board Of Regents Narcistatin prodrugs
WO2005089736A2 (en) * 2004-03-05 2005-09-29 The Arizona Board Of Regents, On Behalf Of, Arizona State University Methods for treating inflammatory and autoimmune diseases
RU2007130942A (ru) 2005-01-14 2009-02-20 АРИЗОНА БОРД ОФ РИДЖЕНТС, э боди корпорейт оф дзе Стейт оф Аризона эктинг фор энд он бихаф оф АРИЗОНА СТЕЙТ ЮНИВЕРСИТИ (US) Синтез нарцистатина натрия и родственных соединений
WO2006122723A1 (en) * 2005-05-19 2006-11-23 Vaecgene Biotech Gmbh Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections
FR2934266B1 (fr) 2008-07-28 2010-09-17 Pf Medicament Derives azotes de la pancratistatine
WO2011137925A1 (en) * 2010-05-03 2011-11-10 Universite Libre De Bruxelles New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
WO2016130969A1 (en) 2015-02-13 2016-08-18 George Robert Pettit Silstatin compounds
WO2019094709A1 (en) 2017-11-09 2019-05-16 Pettit George R Betulastatin compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4985436A (en) * 1984-02-17 1991-01-15 Arizona Board Of Regents Composition of matter for inhibiting leukemias and sarcomas
US5529989A (en) 1995-01-09 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Pancratistatin prodrug
US5830850A (en) 1996-08-28 1998-11-03 Mount Sinai School Of Medicine Of The City Of New York Methods for the treatment of bone resorption disorders, including osteoporosis
JP3660072B2 (ja) 1996-09-26 2005-06-15 シャープ株式会社 光磁気記録媒体及びその記録方法並びに光磁気記録装置
JPH11255650A (ja) 1998-03-12 1999-09-21 Kanegafuchi Chem Ind Co Ltd アポトーシス抑制剤
JP2002537262A (ja) 1999-02-18 2002-11-05 オキシジェン，インコーポレイティド 血管破壊のターゲッティングに使用するための組成物および方法
GB0122731D0 (en) 2001-09-20 2001-11-14 Univ Strathclyde Anti-inflammatory agent
US7462609B2 (en) * 2002-12-09 2008-12-09 Arizona Board Of Regents Narcistatin prodrugs

Also Published As

Publication number Publication date
EP1585750A4 (de) 2007-08-22
US7994320B2 (en) 2011-08-09
EP1990346A2 (de) 2008-11-12
US20090082569A1 (en) 2009-03-26
WO2004052298A3 (en) 2004-09-30
WO2004052298A2 (en) 2004-06-24
US20060135481A1 (en) 2006-06-22
EP1585750B1 (de) 2008-10-15
US7462609B2 (en) 2008-12-09
EP1990346A3 (de) 2009-02-18
EP1585750A2 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
DE50306589D1 (de) Wischblatt
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DE50212349D1 (de) Hirurgie
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50301200D1 (de) Wischblatt
ATE349458T1 (de) Etonogestrelester
DE50309536D1 (de) Fadenabsaugvorrichtung
DE50310481D1 (de) Röntgenstativ
ATA1572002A (de) Managementspleisskassette
DE50307971D1 (de) Gelenklager
DE50302660D1 (de) Stopfmachine
DE50301960D1 (de) Hydrolager
DE50309499D1 (de) Librierwerkzeugen
DE50301464D1 (de) Schraubensicherung
ATA4142004A (de) Trägerverbau
DE60324196D1 (de) Narcistatin-prodrugs
ATE469773T1 (de) Zugöse
DE50305973D1 (de) Auffangwanne
DE50303317D1 (de) Einschub-leistungsschalter
DE50307628D1 (de) Getraenkehalter
ATA19152002A (de) Hubkupplung
DE50308979D1 (de) Einspritzventil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition